SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.

Share ownership Shijiazhuang Yiling Pharmaceutical Co., Ltd.

002603

CNE1000015S0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-03-10			5-day change	1st Jan Change
16.91 ^CNY	+0.77%		+2.55%	-0.94%

03-04	Yiling Pharmaceutical Unit Gets Nod to Market Anti-Tumor Drug	MT
01-23	Yiling Pharma's Unit Gets Nod for Registration of Aniline Profen Injection	MT

Share class: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	1,670,705,376	711,868,739 ( 42.61 %)	0	42.61 %

Major shareholders: Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Name	Equities	%	Valuation
China Southern Asset Management Co., Ltd. 0.9498 %	13,068,679	0.9498 %	33 M ¥
China Asset Management Co., Ltd. 0.1617 %	2,224,391	0.1617 %	6 M ¥
China Merchants Fund Management Co., Ltd. 0.1597 %	2,198,100	0.1597 %	6 M ¥
Penghua Fund Management Co., Ltd. 0.1449 %	1,994,420	0.1449 %	5 M ¥
Shanghai Guotai Junan Securities Assets Management Co., Ltd. 0.1126 %	1,549,900	0.1126 %	4 M ¥
Galaxy Asset Management Co., Ltd. 0.1018 %	1,400,800	0.1018 %	4 M ¥
Tian Hong Asset Management Co., Ltd. 0.0884 %	1,215,767	0.0884 %	3 M ¥
State Street Global Advisors Ltd. 0.0882 %	1,213,508	0.0882 %	3 M ¥
Huatai-PineBridge Fund Management Co., Ltd. 0.0788 %	1,083,772	0.0788 %	3 M ¥
Guotai Asset Management Co., Ltd. 0.0731 %	1,005,202	0.0731 %	3 M ¥
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	2.52%
Unknown	97.48%

Based on 1000 largest holdings

Geographical origin of shareholders

China	2.42%
United Kingdom	0.09%

Based on 1000 largest holdings

Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company principally engaged in research, development, production and sales of patented innovative traditional Chinese medicine. The Company operates three business sectors. The Proprietary Chinese Medicine sector is mainly engaged in multi-channel research and development of compound Chinese medicines, component Chinese medicines and single Chinese medicines. The Chemopharmaceutical sector mainly establishes chemopharmaceutical research and development platform, international standard production platform and network of overseas sales partners. The Health Industry sector has developed and launched a series of health products, including products of benefiting heart and brain, anti-aging and immunity, anti-fatigue and anti-joint, sleep and mood and Lianhua respiratory health. The Company also provides dietary supplements, healthy food and drink, disinfection products and personal protective equipment.

Employees

11,708

Sector

Pharmaceuticals

Calendar

04-28 - Earnings release - Annual 2025

More about the company